Skip to main content
. 2019 Jun 25;321(24):2414–2427. doi: 10.1001/jama.2019.8145

Figure 1. Participant Flow in the STOPDAPT-2 Randomized Clinical Trial.

Figure 1.

CoCr-EES indicates cobalt-chromium everolimus-eluting stent.

aA total of 183 patients had planned staged procedure and received other drug-eluting stents, so numbers are not mutually exclusive.